Giliead Under Fire For Withholding PrEP Patents

United States (US) headquartered pharmaceutical company Gilead Sciences, is being accused of engaging in inhuman practices of holding on to patents for certain lifesaving drugs, a situation that has condemned millions to new HIV infections and premature deaths. By Kudakwashe Pembere Some of the practices include ever-greening of medicine patents like Truvada which has been in use as a pre-exposure prophylaxis (PrEP) in many countries like Zimbabwe as well as opening the license for the generic production of the hepatitis C drug Harvoni to all low- and middle-income countries. AIDS…

Read More